Key clinical point: Certain antidiabetes medications may protect against dementia.
Major finding: Type 2 diabetes patients whose treatment regimen included an SGLT2 inhibitor were 62% less likely to develop dementia.
Study details: This Danish national case control registry study included 11,619 type 2 diabetes patients who received a dementia diagnosis and 46,476 matched type 2 diabetes patients without dementia.
Disclosures: The presenter reported having no financial conflicts of interest regarding the study, which was funded by the Danish Diabetes Foundation, the Danish Medical Association, and other foundations.
Osler M. ECNP Abstract P180.